Bangsund: Vaccines are brightening the outlook for a return to normalcy this year

by

About This Source - CNBC Television

Recent from CNBC Television:

  • C3.ai founder and CEO Tom Siebel on third quarter earnings and outlook
  • Cleo Capital’s Sarah Kunst on why tech stocks are high
  • Cannabis company Parallel CEO Beau Wrigley on going public via SPAC

    • CNBC Television published this video item, entitled “Bangsund: Vaccines are brightening the outlook for a return to normalcy this year” – below is their description.

    Candice Bangsund of Fiera Capital discusses how the vaccine rollout, prospects of stronger growth and ample liquidity from monetary and fiscal support will help stocks make new highs this year.

    CNBC Television YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: Vaccine

    A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.

    9 Recent Items: Vaccine

  • German exports to UK slump after Brexit
  • Nigeria Receives Nearly 4 Million Covid Vaccine Doses Via Covax Program
  • AmerisourceBergen CEO on how U.S. vaccine distribution is going
  • France recommends single vaccine dose for people who have had Covid-19
  • A Year Into the Coronavirus Pandemic, 3 Vaccines Cleared in U.S., 7 Worldwide
  • Coronavirus: 245 Million Covid Vaccine Doses Have Been Given in 107 Countries
  • Coronavirus: Vaccine Booster Shots in Development to Target Covid Variants
  • How Merck could assist J&J’s covid vaccine manufacturing efforts
  • CDC chief warns of ‘potential fourth surge’ of coronavirus in US

    • Leave a Comment